139 related articles for article (PubMed ID: 1646210)
1. Immobilization of dermatan sulphate on a silica matrix and its possible use as an affinity chromatography support for heparin cofactor II purification.
Sinniger V; Tapon-Bretaudière J; Zhou FL; Bros A; Muller D; Jozefonvicz J; Fischer AM
J Chromatogr; 1991 Feb; 539(2):289-96. PubMed ID: 1646210
[TBL] [Abstract][Full Text] [Related]
2. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
Halldórsdóttir AM; Zhang L; Tollefsen DM
Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
[TBL] [Abstract][Full Text] [Related]
3. Purification of heparin cofactor II from human plasma.
Toulon P; Chadeuf G; Aiach M
J Chromatogr; 1991 Feb; 539(2):493-500. PubMed ID: 2045458
[TBL] [Abstract][Full Text] [Related]
4. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
[TBL] [Abstract][Full Text] [Related]
5. The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II.
Verhamme IM; Bock PE; Jackson CM
J Biol Chem; 2004 Mar; 279(11):9785-95. PubMed ID: 14701814
[TBL] [Abstract][Full Text] [Related]
6. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
Blinder MA; Tollefsen DM
J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli.
Sarilla S; Habib SY; Tollefsen DM; Friedman DB; Arnett DR; Verhamme IM
Anal Biochem; 2010 Nov; 406(2):166-75. PubMed ID: 20670608
[TBL] [Abstract][Full Text] [Related]
8. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
Maimone MM; Tollefsen DM
J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
[TBL] [Abstract][Full Text] [Related]
10. Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases.
Langford-Smith KJ; Mercer J; Petty J; Tylee K; Church H; Roberts J; Moss G; Jones S; Wynn R; Wraith JE; Bigger BW
J Inherit Metab Dis; 2011 Apr; 34(2):499-508. PubMed ID: 21170681
[TBL] [Abstract][Full Text] [Related]
11. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
Sheehan JP; Tollefsen DM; Sadler JE
J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
[TBL] [Abstract][Full Text] [Related]
12. Affinity chromatography of sulphated polysaccharides separately fractionated on antithrombin III and heparin cofactor II immobilized on concanavalin A--sepharose.
Sinniger V; Tapon-Bretaudière J; Millien C; Muller D; Jozefonvicz J; Fischer AM
J Chromatogr; 1993 Jun; 615(2):215-23. PubMed ID: 8335699
[TBL] [Abstract][Full Text] [Related]
13. Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque.
Shirk RA; Parthasarathy N; San Antonio JD; Church FC; Wagner WD
J Biol Chem; 2000 Jun; 275(24):18085-92. PubMed ID: 10749870
[TBL] [Abstract][Full Text] [Related]
14. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
Tollefsen DM
Adv Exp Med Biol; 1992; 313():167-76. PubMed ID: 1442260
[TBL] [Abstract][Full Text] [Related]
15. Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II.
Giri TK; Tollefsen DM
Blood; 2006 Apr; 107(7):2753-8. PubMed ID: 16339402
[TBL] [Abstract][Full Text] [Related]
16. Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins.
Petzelbauer E; Seiffert D; Beckmann R; Pusch B; Geiger M; Binder BR
Thromb Res; 1992 Jun; 66(5):559-67. PubMed ID: 1381850
[TBL] [Abstract][Full Text] [Related]
17. The interaction of glycosaminoglycans with heparin cofactor II.
Tollefsen DM
Ann N Y Acad Sci; 1994 Apr; 714():21-31. PubMed ID: 8017769
[TBL] [Abstract][Full Text] [Related]
18. Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II.
He L; Giri TK; Vicente CP; Tollefsen DM
Blood; 2008 Apr; 111(8):4118-25. PubMed ID: 18281504
[TBL] [Abstract][Full Text] [Related]
19. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
[TBL] [Abstract][Full Text] [Related]
20. Activation of heparin cofactor II by dermatan sulfate.
Tollefsen DM; Pestka CA; Monafo WJ
J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
